Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28387994 | 0.89 | KDM4E (0.43) | KDM4ETDP1MMP3ENPP2 | |
| SCHEMBL5201126 | 0.89 | KDM4E (0.43) | KDM4ETDP1CYP2A6MMP3PTGS2 | |
| SCHEMBL10069585 | 0.82 | PTGS2 (0.44) | CYP2A6PTGS2 | |
| SCHEMBL18640647 | 0.82 | PTGS2 (0.44) | CYP2A6PTGS2 | |
| SCHEMBL12883530 | 0.81 | KDM4E (0.38) | KDM4ETDP1CYP2A6MMP3PTGS2 | |
| SCHEMBL14723952 | 0.79 | PTGS2 (0.33) | PTGS2 | |
| SCHEMBL4007007 | 0.76 | KDM4E (0.52) | KDM4ETDP1MMP3ENPP2 | |
| SCHEMBL21300469 | 0.76 | ALDH1A1 (0.35) | KDM4ETDP1CYP2A6MMP3ENPP2 | |
| SCHEMBL25370593 | 0.75 | KDM4E (0.34) | KDM4ETDP1CYP2A6MMP3 | |
| SCHEMBL25371047 | 0.75 | KDM4E (0.34) | KDM4ETDP1CYP2A6MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1994014-A1 | IMPROVED PROCESS FOR HIGH PURITY ANASTROZOLE | Shilpa Medicare Limited (IN) | 2008-11-26 | — | — | EP | disclosed |
| WO-2007105231-A1 | IMPROVED PROCESS FOR HIGH PURITY ANASTROZOLE | SHILPA MEDICARE LTD. (IN) | 2007-09-20 | — | — | WO | disclosed |